CARDINAL HEALTH, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 102.7 USD | +0.56% |
|
-0.95% | +2.00% |
| 07:04pm | Leerink Partners Adjusts Cardinal Health Price Target to $120 From $118 | MT |
| 02:30pm | Transcript : Cardinal Health, Inc., Q3 2024 Earnings Call, May 02, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Cardinal Health, Inc. is specialized in the distribution of products and health services to pharmacies, hospitals and medical practices. Net sales break down by activity as follows:
- distribution of pharmaceutical products (92.7%);
- distribution of medical, surgical and laboratory products (7.3%). The group also develops a manufacturing of medical and surgical products activity (masks, overalls, gloves, diagnostic products, products of aspiration and collection of liquids, radiology intervention, respiratory assistance, etc.).
The United States accounts for 97.7% of net sales.
Sector
Pharmaceuticals
Calendar
2024-05-01
- Q3 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
102.2
USD
Average target price
112.3
USD
Spread / Average Target
+9.92%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +2.00% | 24.85B | |
| +14.54% | 69.79B | |
| +7.11% | 8.2B | |
| -20.55% | 7.96B | |
| -5.04% | 7.91B | |
| +2.32% | 4.69B | |
| +17.12% | 4.32B | |
| -1.24% | 3.99B | |
| -3.78% | 3.81B | |
| +21.42% | 3.62B |
- Stock Market
- Equities
- CAH Stock
- News Cardinal Health, Inc.
- Mizuho Raises Price Target on Cardinal Health to $94 From $85, Maintains Neutral Rating
